Skip to content

VIVAPHARMA

Active
Private limited companyfounded 2019active for 6 yearsWaverse steenweg 1585, 1160 Oudergem, BelgiumKBO/BCE: BE 0740.481.964
Summary

VIVAPHARMA has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €126,780 and a net result of €118,241. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 68% of 5,017 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

History

VIVAPHARMA was incorporated on 26 December 2019 as a private limited company.1 Total assets rose from €188,136 in 2020 to €236,296 in 2025 and headcount from 0.7 full-time equivalents in 2020 to 0.2 in 2024.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020, 2024 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
08-06
NBB filing Annual accounts filed
financial year 2025 · full format
12-01
Gazette deed Resignation: Azzam Moussa (director)
Appointment: Turki Eya (director) · Director discharge4 facts ▸
  • General meeting, 22-12-2025
  • Director resignation, Azzam Moussa (director)
  • Director appointment, Turki Eya (director)
  • Director discharge, Azzam Moussa
2025
31-12
Financial Highest result from 2020 to 2025net €118,241 ▲41%
Operating result €160,984, net result €118,241, both a record.
31-12
Financial Liquidity more than doubledcurrent ratio 3.12
Current ratio from 1.13 to 3.12; short-term debt falls from €134,142 to €62,522.
31-12
Financial Equity above €100,000equity €126,780 ▲1,385%
2 profitable years in a row build equity to €126,780.
19-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Back to profitnet €83,847
Net result €83,847 after 2 loss-making years.
05-07
Gazette deed Resignations: Nina MAMAGHANI (director) and Sophie GYSEMBERG (director)
Appointment: Moussa AZZAM (director) · Director discharge7 facts ▸
  • General meeting, 31-05-2024
  • Director resignation, Nina MAMAGHANI (director)
  • Director resignation, Sophie GYSEMBERG (director)
  • Director discharge, Nina MAMAGHANI
  • Director discharge, Sophie GYSEMBERG
  • Director appointment, Moussa AZZAM (director)
  • Board meeting, “administrateur, ensuite” (deed in French)
12-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
27-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
09-06
NBB filing Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial Back to profitnet €33,958
Net result €33,958 after one loss-making year.
07-06
NBB filing Annual accounts filed
financial year 2020 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 3 deeds read
About the unread acts

Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.